These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 28193908)
1. Role of the PEBP4 protein in the development and metastasis of gastric cancer. Wu Z; Liu B; Zheng X; Hou H; Li Y Oncotarget; 2017 Mar; 8(11):18177-18184. PubMed ID: 28193908 [TBL] [Abstract][Full Text] [Related]
2. Knockdown of PEBP4 suppresses proliferation, migration and invasion of human breast cancer cells. Wang SC; Zhou F; Zhou ZY; Hu Z; Chang L; Ma MD Biomed Pharmacother; 2017 Jun; 90():659-664. PubMed ID: 28415045 [TBL] [Abstract][Full Text] [Related]
3. PEBP4 silencing inhibits hypoxia-induced epithelial-to-mesenchymal transition in prostate cancer cells. Li W; Dong Y; Zhang B; Kang Y; Yang X; Wang H Biomed Pharmacother; 2016 Jul; 81():1-6. PubMed ID: 27261570 [TBL] [Abstract][Full Text] [Related]
4. PEBP4 promoted the growth and migration of cancer cells in pancreatic ductal adenocarcinoma. Zhang D; Dai Y; Cai Y; Suo T; Liu H; Wang Y; Cheng Z; Liu H Tumour Biol; 2016 Feb; 37(2):1699-705. PubMed ID: 26311050 [TBL] [Abstract][Full Text] [Related]
5. Knockdown of PEBP4 inhibits human glioma cell growth and invasive potential via ERK1/2 signaling pathway. Huang RQ; Wang SQ; Zhu QB; Guo SC; Shi DL; Chen F; Fang YC; Chen R; Lu YC Mol Carcinog; 2019 Jan; 58(1):135-143. PubMed ID: 30255656 [TBL] [Abstract][Full Text] [Related]
6. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT. Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851 [TBL] [Abstract][Full Text] [Related]
7. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN. Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739 [TBL] [Abstract][Full Text] [Related]
8. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production. Zhou H; Wu J; Wang T; Zhang X; Liu D Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388 [TBL] [Abstract][Full Text] [Related]
9. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway. Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138 [TBL] [Abstract][Full Text] [Related]
10. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer. Lin HL; Yang MH; Wu CW; Chen PM; Yang YP; Chu YR; Kao CL; Ku HH; Lo JF; Liou JP; Chi CW; Chiou SH Int J Cancer; 2007 Dec; 121(11):2547-55. PubMed ID: 17680560 [TBL] [Abstract][Full Text] [Related]
11. Omental adipocytes enhance the invasiveness of gastric cancer cells by oleic acid-induced activation of the PI3K-Akt signaling pathway. Xiang F; Wu K; Liu Y; Shi L; Wang D; Li G; Tao K; Wang G Int J Biochem Cell Biol; 2017 Mar; 84():14-21. PubMed ID: 27956048 [TBL] [Abstract][Full Text] [Related]
12. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression. Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392 [TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320 [TBL] [Abstract][Full Text] [Related]
14. PEBP4 Directs the Malignant Behavior of Hepatocellular Carcinoma Cells via Regulating mTORC1 and mTORC2. Chen Q; Jin J; Guo W; Tang Z; Luo Y; Ying Y; Lin H; Luo Z Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955931 [TBL] [Abstract][Full Text] [Related]
15. Suppression of SHIP2 contributes to tumorigenesis and proliferation of gastric cancer cells via activation of Akt. Ye Y; Ge YM; Xiao MM; Guo LM; Li Q; Hao JQ; Da J; Hu WL; Zhang XD; Xu J; Zhang LJ J Gastroenterol; 2016 Mar; 51(3):230-40. PubMed ID: 26201869 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of TMPRSS3 inhibits gastric cancer cell proliferation, invasion and EMT via regulation of the ERK1/2 and PI3K/Akt pathways. Li SL; Chen X; Wu T; Zhang XW; Li H; Zhang Y; Ji ZZ Biomed Pharmacother; 2018 Nov; 107():841-848. PubMed ID: 30142546 [TBL] [Abstract][Full Text] [Related]
17. Knockdown of CEACAM19 suppresses human gastric cancer through inhibition of PI3K/Akt and NF-κB. Zhao H; Xu J; Wang Y; Jiang R; Li X; Zhang L; Che Y Surg Oncol; 2018 Sep; 27(3):495-502. PubMed ID: 30217308 [TBL] [Abstract][Full Text] [Related]
18. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway. Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034 [TBL] [Abstract][Full Text] [Related]
19. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits. Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187 [TBL] [Abstract][Full Text] [Related]
20. Isoliquiritigenin inhibits proliferation and metastasis of MKN28 gastric cancer cells by suppressing the PI3K/AKT/mTOR signaling pathway. Zhang XR; Wang SY; Sun W; Wei C Mol Med Rep; 2018 Sep; 18(3):3429-3436. PubMed ID: 30066879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]